AllianceBernstein’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-75,407
| Closed | -$1.35M | – | 3091 |
|
|
2017
Q4 | $1.35M | Buy |
75,407
+37,045
| +97% | +$456K | ﹤0.01% | 2101 |
|
|
2017
Q3 | $453K | Hold |
38,362
| – | – | ﹤0.01% | 2609 |
|
|
2017
Q2 | $403K | Buy |
38,362
+9,000
| +31% | +$91.7K | ﹤0.01% | 2691 |
|
|
2017
Q1 | $323K | Sell |
29,362
-273,390
| -90% | -$3.17M | ﹤0.01% | 2681 |
|
|
2016
Q4 | $4.1M | Buy |
302,752
+247,790
| +451% | +$3.46M | ﹤0.01% | 1317 |
|
|
2016
Q3 | $677K | Hold |
54,962
| – | – | ﹤0.01% | 2399 |
|
|
2016
Q2 | $603K | Sell |
54,962
-20,390
| -27% | -$228K | ﹤0.01% | 2445 |
|
|
2016
Q1 | $824K | Buy |
75,352
+26,080
| +53% | +$330K | ﹤0.01% | 2205 |
|
|
2015
Q4 | $852K | Sell |
49,272
-1,050
| -2% | -$18.8K | ﹤0.01% | 2219 |
|
|
2015
Q3 | $1M | Buy |
50,322
+5,860
| +13% | +$134K | ﹤0.01% | 2175 |
|
|
2015
Q2 | $731K | Buy |
44,462
+5,100
| +13% | +$88.4K | ﹤0.01% | 2433 |
|
|
2015
Q1 | $612K | Buy |
39,362
+11,100
| +39% | +$172K | ﹤0.01% | 2409 |
|
|
2014
Q4 | $404K | Sell |
28,262
-6,700
| -19% | -$70.8K | ﹤0.01% | 2588 |
|
|
2014
Q3 | $227K | Hold |
34,962
| – | – | ﹤0.01% | 2730 |
|
|
2014
Q2 | $241K | Buy |
34,962
+176
| +0.5% | +$1.24K | ﹤0.01% | 2757 |
|
|
2014
Q1 | $249K | Sell |
34,786
-3,200
| -8% | -$27.4K | ﹤0.01% | 2694 |
|
|
2013
Q4 | $357K | Hold |
37,986
| – | – | ﹤0.01% | 2596 |
|
|
2013
Q3 | $237K | Sell |
37,986
-1,277
| -3% | -$7.98K | ﹤0.01% | 2803 |
|
|
2013
Q2 | $258K | Buy |
+39,263
| New | +$311K | ﹤0.01% | 2760 |
|
Other funds holding SCMP
AllianceBernstein's SCMP Position: Q1 2018 in Review
AllianceBernstein sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 75,407 shares — an estimated $1.35M sold.
AllianceBernstein first reported a position in SCMP in Q2 2013 and held it in 19 quarters. The position peaked at $4.1M in Q4 2016. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- AllianceBernstein reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- AllianceBernstein sold 75,407 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.35M.
- AllianceBernstein first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- AllianceBernstein's Sucampo Pharmaceuticals, Inc. position peaked at $4.1M in Q4 2016.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on AllianceBernstein's 13F filing for Q1 2018, filed 14 May 2018.